Literature DB >> 4208419

The nicotinic cholinergic receptor protein: improved purification method, preliminary amino acid composition and observed auto-immuno response.

E Heilbronn, C Mattson.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4208419     DOI: 10.1111/j.1471-4159.1974.tb11597.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


× No keyword cloud information.
  6 in total

1.  A compilation of amino acid analyses of proteins : XVII. Residues per thousand residues-4.

Authors:  D M Kirschenbaumt
Journal:  Appl Biochem Biotechnol       Date:  1982-09       Impact factor: 2.926

2.  Induction of the morphologic changes of both acute and chronic experimental myasthenia by monoclonal antibody directed against acetylcholine receptor.

Authors:  C M Gomez; R L Wollmann; D P Richman
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

3.  Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptors.

Authors:  C B Weinberg; Z W Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

4.  Experimental myasthenia in Balb/c mice immunized with rat acetylcholine receptor from rat denervated muscle.

Authors:  D A Granato; B W Fulpius; J F Moody
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

5.  Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis.

Authors:  A Aharonov; R Tarrab-Hazdai; O Abramsky; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

Review 6.  Pursuing High-Resolution Structures of Nicotinic Acetylcholine Receptors: Lessons Learned from Five Decades.

Authors:  Manuel Delgado-Vélez; Orestes Quesada; Juan C Villalobos-Santos; Rafael Maldonado-Hernández; Guillermo Asmar-Rovira; Raymond C Stevens; José Antonio Lasalde-Dominicci
Journal:  Molecules       Date:  2021-09-23       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.